Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer.
Breast Cancer Res. 2019 Oct 22;21(1):116. doi: 10.1186/s13058-019-1205-1.
Breast Cancer Res. 2019.
PMID: 31640747
Free PMC article.
Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study.
Sankaranarayanan RA, Peil J, Vogg ATJ, Bolm C, Terhorst S, Classen A, Bauwens M, Maurer J, Mottaghy F, Morgenroth A.
Sankaranarayanan RA, et al.
Cancers (Basel). 2022 Jan 4;14(1):230. doi: 10.3390/cancers14010230.
Cancers (Basel). 2022.
PMID: 35008392
Free PMC article.
Item in Clipboard
Simple plant-based production and purification of the assembled human ferritin heavy chain as a nanocarrier for tumor-targeted drug delivery and bioimaging in cancer therapy.
Knödler M, Opdensteinen P, Sankaranarayanan RA, Morgenroth A, Buhl EM, Mottaghy FM, Buyel JF.
Knödler M, et al. Among authors: sankaranarayanan ra.
Biotechnol Bioeng. 2023 Apr;120(4):1038-1054. doi: 10.1002/bit.28312. Epub 2023 Jan 2.
Biotechnol Bioeng. 2023.
PMID: 36539373
Item in Clipboard
Correction: PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer.
Sankaranarayanan RA, Florea A, Allekotte S, Vogg ATJ, Maurer J, Schäfer L, Bolm C, Terhorst S, Classen A, Bauwens M, Morgenroth A, Mottaghy FM.
Sankaranarayanan RA, et al.
EJNMMI Res. 2023 Feb 10;13(1):12. doi: 10.1186/s13550-023-00961-y.
EJNMMI Res. 2023.
PMID: 36763205
Free PMC article.
No abstract available.
Item in Clipboard
Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14, 230.
Sankaranarayanan RA, Peil J, Vogg ATJ, Bolm C, Terhorst S, Classen A, Bauwens M, Maurer J, Mottaghy F, Morgenroth A.
Sankaranarayanan RA, et al.
Cancers (Basel). 2023 May 6;15(9):2641. doi: 10.3390/cancers15092641.
Cancers (Basel). 2023.
PMID: 37174130
Free PMC article.
Item in Clipboard
Prostate-Specific Membrane Antigen Targeted StarPEG Nanocarrier for Imaging and Therapy of Prostate Cancer.
Meher N, Ashley GW, Bobba KN, Wadhwa A, Bidkar AP, Dasari C, Mu C, Sankaranarayanan RA, Serrano JAC, Raveendran A, Bulkley DP, Aggarwal R, Greenland NY, Oskowitz A, Wilson DM, Seo Y, Santi DV, VanBrocklin HF, Flavell RR.
Meher N, et al. Among authors: sankaranarayanan ra.
Adv Healthc Mater. 2024 May 3:e2304618. doi: 10.1002/adhm.202304618. Online ahead of print.
Adv Healthc Mater. 2024.
PMID: 38700450
Item in Clipboard
Cite
Cite